About: Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.43 (+10.00%)
CMMB NASDAQ Chemomab Therapeutics Ltd DRC
Chemomab Therapeutics Ltd DRC share price
CMMB price activity
Last Price
$1.430
Change (24hr)
0.13 USD (10.00%)
Volume
40.76K
Volume (4w avg)
-
Open
$1.30
Day Range
$1.30 - $1.44
Previous Close
$1.30
Last Trade
02 Oct, 8:00 pm GMT+0
Delayed
02 Oct, 8:00 pm GMT+0
CMMB price performance
Delayed
02 Oct, 8:00 pm GMT+0
CMMB Market Signals